| abstract |
The present invention relates to a polypeptide comprising any of the following amino acid sequences: (A) the amino acid sequence represented by SEQ ID NO: 4 or SEQ ID NO: 8, (B) 1 to 10, preferably 1 to 5, more preferably 1, 2 or 3 amino acids are substituted, deleted, added or inserted in the amino acid sequence represented by SEQ ID NO: 4 or 8 An amino acid sequence, and (c) an amino acid sequence having 95% or more, more preferably 97% or more, more preferably 99% or more of the amino acid sequence represented by SEQ ID NO: 4 or SEQ ID NO: 8, and the polypeptide Malaria vaccine including |